Analysis of water patterns in protein kinase binding sites

被引:21
作者
Barillari, Caterina [1 ,2 ,3 ]
Duncan, Anna L. [4 ]
Westwood, Isaac M. [1 ,2 ,3 ]
Blagg, Julian [1 ,3 ]
van Montfort, Rob L. M. [1 ,2 ,3 ]
机构
[1] Inst Canc Res, Haddow Labs, Sect Canc Therapeut, Sutton SM2 5NG, Surrey, England
[2] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England
[3] Inst Canc Res, Haddow Labs, Canc Res UK Canc Therapeut Unit, Sutton SM2 5NG, Surrey, England
[4] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England
基金
英国工程与自然科学研究理事会;
关键词
water molecules; kinase; selectivity; binding site similarity; drug design; DRUG DESIGN; FUNCTIONAL CLASSIFICATION; SIMILARITY ANALYSIS; CRYSTAL-STRUCTURE; TYROSINE KINASES; SERINE PROTEASES; INHIBITORS; MOLECULES; POTENT; HYDRATION;
D O I
10.1002/prot.23032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deregulation of protein kinases is associated with numerous diseases, making them important targets for drug discovery. The majority of drugs target the catalytic site of these proteins, but due to the high level of similarity within the ATP binding sites of protein kinases, it is often difficult to achieve the required pharmacological selectivity. In this study, we describe the identification and subsequent analysis of water patterns in the ATP binding sites of 171 protein kinase structures, comprising 19 different kinases from various branches of the kinome, and demonstrate that structurally similar binding sites often have significantly different water patterns. We show that the observed variations in water patterns of different, but structurally similar kinases can be exploited in the structure-based design of potent and selective kinase inhibitors.
引用
收藏
页码:2109 / 2121
页数:13
相关论文
共 44 条
[1]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[2]  
[Anonymous], PYMOL MOL GRAPH SYST
[3]   Classification of water molecules in protein binding sites [J].
Barillari, Caterina ;
Taylor, Justine ;
Viner, Russell ;
Essex, Jonathan W. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (09) :2577-2587
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer [J].
Brough, Paul A. ;
Aherne, Wynne ;
Barril, Xavier ;
Borgognoni, Jenifer ;
Boxall, Kathy ;
Cansfield, Julie E. ;
Cheung, Kwai-Miny J. ;
Collins, Ian ;
Davies, Nicholas G. M. ;
Drysdale, Martin J. ;
Dymock, Brian ;
Eccles, Suzanne A. ;
Finch, Harry ;
Fink, Alexandra ;
Hayes, Angela ;
Howes, Robert ;
Hubbard, Roderick E. ;
James, Karen ;
Jordan, Allan M. ;
Lockie, Andrea ;
Martins, Vanessa ;
Massey, Andrew ;
Matthews, Thomas P. ;
McDonald, Edward ;
Northfield, Christopher J. ;
Pearl, Laurence H. ;
Prodromou, Chrisostomos ;
Ray, Stuart ;
Raynaud, Florence I. ;
Roughley, Stephen D. ;
Sharp, Swee Y. ;
Surgenor, Allan ;
Walmsley, D. Lee ;
Webb, Paul ;
Wood, Mike ;
Workman, Paul ;
Wrightt, Lisa .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (02) :196-218
[6]  
Chemical Computing Group Inc, 2008, MOL OP ENV MOE
[7]   Features and development of Coot [J].
Emsley, P. ;
Lohkamp, B. ;
Scott, W. G. ;
Cowtan, K. .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2010, 66 :486-501
[8]   Insights for the development of specific kinase inhibitors by targeted structural genomics [J].
Fedorov, Oleg ;
Sundstrom, Michael ;
Marsden, Brian ;
Knapp, Stefan .
DRUG DISCOVERY TODAY, 2007, 12 (9-10) :365-372
[9]   An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic [J].
Fernandez, Ariel ;
Sanguino, Angela ;
Peng, Zhenghong ;
Ozturk, Eylem ;
Chen, Jianping ;
Crespo, Alejandro ;
Wulf, Sarah ;
Shavrin, Aleksander ;
Qin, Chaoping ;
Ma, Jianpeng ;
Trent, Jonathan ;
Lin, Yvonne ;
Han, Hee-Dong ;
Mangala, Lingegowda S. ;
Bankson, James A. ;
Gelovani, Juri ;
Samarel, Allen ;
Bornmann, William ;
Sood, Anil K. ;
Lopez-Berestein, Gabriel .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :4044-4054
[10]   Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding mode [J].
Finlay, M. Raymond V. ;
Acton, David G. ;
Andrews, David M. ;
Barker, Andrew J. ;
Dennis, Michael ;
Fisher, Eric ;
Graham, Mark A. ;
Green, Clive P. ;
Heaton, David W. ;
Karoutchi, Galith ;
Loddick, Sarah A. ;
Morgentin, Remy ;
Roberts, Andrew ;
Tucker, Julie A. ;
Weir, Hazel M. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) :4442-4446